Abstract
Iron is an essential component of every living organism. Iron excess and deficiency are equally detrimental for the cell and thus species longevity . They cause very large number of health disorders and organ system dysfunctions, especially development of age related diseases in elderly people. Iron deficiency increases morbidity and mortality because it causes growth arrest and cell death. Age-related accumulation of iron increases the potential for free redox-active iron, which can promote oxidative stress and mitochondrial damage and thus functional alterations of antioxidant enzymes and further increased oxidative damage to DNA, RNA, proteins, and lipids in tissues in elderly people. This further increases the risk for cancer , liver diseases, cardiovascular disorders associated with atherosclerosis, diabetes mellitus , osteoarthritis, osteoporosis, metabolic syndrome, hypothyroidism, hypogonadism, numerous symptoms and neurodegenerative disorders which accompany ageing (Alzheimer’s, early-onset Parkinson’s, Huntington’s, epilepsy, multiple sclerosis, etc.). Experimental animal studies provide new insights in iron manipulation mechanisms (ferritin, frataxin, mitochondrial autophagy) involved in species longevity and suggest further investigation to elucidate possible application for treatment in human degenerative and age-related diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aapro M, Österborg A, Gascón P, Ludwig H, Beguin Y (2012) Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of iv. Ann Oncol 23(8):1954–1962
Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. J Res Med Sci. 19(2):164–174
Ajmera AV, Shastri GS, Gajera MJ, Judge TA (2012) Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther 19:185–189
Akatsuka S, Aung TT, Dutta KK, Jiang L, Lee WH, Liu YT, Onuki J, Shirase T, Yamasaki K, Ochi H, Naito Y, Yoshikawa T, Kasai H, Tominaga Y, Sakumi K, Nakabeppu Y, Kawai Y, Uchida K, Yamasaki A, Tsuruyama T, Yamada Y, Toyokuni S (2006) Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis. Am J Pathol 169:1328–1342
Alfonzo-González G, Doucet E, Bouchard C, Tremblay A (2006) Greater than predicted decrease in resting energy expenditure with age: cross-sectional and longitudinal evidence. Eur J Clin Nutr 60(1):18–24
Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer’s disease, Parkinson’s disease and atherosclerosis. J Alzheimers Dis 16(4):879–895
Andziak and Buffenstein (2006) Disparate patterns of age-related changes in lipid peroxidation in long-lived naked mole-rats and shorter-lived mice. Aging Cell. 5(6):525–532
Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ (2001) Blood donations and risk of coronary heart disease in men. Circulation 103:52–57
Bartnikas TB (2014) Liver not making hepcidin? Hemochromatosis! Red cells iron erythropoiesis. Blood 123:3646
Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR (1997) MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 15(1):29–35
Beard JL, Felt B, Schallert T, Burhans M, Connor JR, Georgieff MK (2006) Moderate iron deficiency in infancy: biology and behavior in young rats. Behav Brain Res 170:224–232
Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F (2013) Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. Am J Hematol 88(12):990–996
Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131(3):788–796
Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: targets for therapeutics. J Neurochem 139:179–197
Bergeron RJ, Streiff RR, Elliott GT (1985) Influence of iron on in vivo proliferation and lethality of L1210 cells. J Nutr 115(3):369–374
Bhavanadhar P, Srinivasan VR, Oruganti SS, Adiraju KP (2016) A prospective study on prevalence and causes of anaemia in patients with acute coronary syndrome. J Clin Diagn Res. 10(7):OC01–OC05
Bowers K, Yeung E, Williams MA, Qi L, Tobias DK, Hu FB, Zhang C (2011) A prospective study of prepregnancy dietary iron intake and risk for gestational diabetes mellitus. Diab Care 34(7):1557–1563
Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33(6):403–408
Bradbury MW (1997) Transport of iron in the blood-brain cerebrospinal fluid system. J Neurochem 69:443–454
Brissot P, Ropert M, Le Lan C, Loréal O (2012) Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 1820(3):403–410
Brookes MJ, Boult J, Roberts K, Cooper BT, Hotchin NA, Matthews G, Iqbal T, Tselepis C (2008) A role for iron in Wnt signalling. Oncogene 27(7):966–975
Bross MH, Soch K, Smith-Knuppel T (2010) Anemia in older persons. Am Fam Physician 82(5):480–487
Brouwers JR (1992) Drug interactions with quinolone antibacterials. Drug Saf 7(4):268–281
Brunet S, Thibault L, Delvin E, Yotov W, Bendayan M, Levy E (1999) Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 29:1809–1817
Cabantchik ZI (2014) Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front Pharmacol 5:45
Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P (2005) LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol 18:277–287
Calabrich A, Katz A (2011) Management of anemia in cancer patients. Future Oncol 7(4):507–517
Campbell NR, Hasinoff B (1989) Ferrous sulfate reduces levodopa bioavailability: chelation as a possible mechanism. Clin Pharmacol Ther 45:220–225
Campbell NR, Hasinoff BB (1991) Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol 31:251–255
Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC (1992) Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 117:1010–1013
Cario H, Janka-Schaub G, Janssen G, Jarisch A, Strauss G, Kohne E (2007) Recent developments in iron chelation therapy. Klin Padiatr 219:158–165
Carmona-Gutierrez D, Hughes AL, Madeo F, Ruckenstuhl C (2016) The crucial impact of lysosomes in aging and longevity. Ageing Res Rev 32:2–12
Cassinerio E, Roghi A, Pedrotti P, Brevi F, Zanaboni L, Graziadei G, Pattoneri P, Milazzo A, Cappellini MD (2012) Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients. Ann Hematol 91(9):1443–1449
Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59(3):527–605
Chen X, Yang G, Ding WY, Bondoc F, Curtis SK, Yang CS (1999) An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 20(9):1801–1808
Cheng HL, Bryant C, Cook R, O’Connor H, Rooney K, Steinbeck K (2012) Therelationship between obesity and hypoferraemia in adults: a systematicreview. Obes Rev 13:150–161
Codazzi F, Pelizzoni I, Zacchetti D, Grohovaz F (2015) Iron entry in neurons and astrocytes: a link with synaptic activity. Front Mol Neurosci 8:18
Connor JR, Menzies SL, St Martin SM, Mufson EJ (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 27(4):595–611
Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer’s disease. J Neurosci Res 31(2):327–335
Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA (2004) Oxidativestress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145:5305–5312
Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy JA (2002) Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95(4):888–895
Ćurko-Cofek B, Kezele TG, Marinić J, Tota M, Čizmarević NS, Milin Č, Ristić S, Radošević-Stašić B, Barac-Latas V (2016) Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis. Neurotoxicology 57:1–12
Ćurko-Cofek B, Kezele TG, Barac-Latas V (2017) Hepcidin and metallothioneins as molecular base for sex-dependent differences in clinical course of experimental autoimmune encephalomyelitis in chronic iron overload. Med Hypotheses 107:51–54
Dao MC, Meydani SN (2013) Iron biology, immunology, aging, and obesity: four fields connected by the small peptide hormone hepcidin. Adv Nutr 4(6):602–617
De Das S, Krishna S, Jethwa A (2015) Iron status and its association with coronary heart disease: systematic review and meta-analysis of prospective studies. Atherosclerosis 238:296–303
De Vita F, Maggio M, Lauretani F, Crucitti L, Bandinelli S, Mammarella F, Landi F, Ferrucci L, Ceda GP (2015) Insulin-like growth factor-1 and anemia in older subjects: the inchianti study. Endocr Pract 21(11):1211–1218
Dietary reference intakes for vitamin A, vitamin K, arsenic, Boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc (2001). Institute of Medicine (US) Panel on Micronutrients. Washington, DC. National Academies Press, US
Dotan Y, Pinchuk I, Lichtenberg D, Leshno M (2009) Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good. Arterioscler Thromb Vasc Biol 29(9):1304–1309
Drakesmith H, Prentice A (2008) Viral infection and iron metabolism. Nat Rev Microbiol 6:541–552
Druzhyna NM, Wilson GL, LeDoux SP (2008) Mitochondrial DNA repair in aging and disease. Mech Ageing Dev 126:383–390
Dusek P, Schneider SA, Aaseth J (2016) Iron chelation in the treatment of neurodegenerative diseases. J Trace Elem Med Biol 38:81–92
Eisenstaedt R, Penninx BW, Woodman RC (2006) Anemia in the elderly: current understanding and emerging concepts. Blood Rev 20:213–226
Espinosa de los Monteros A, Kumar S, Scully S, Cole R, de Vellis J (1990) Transferrin gene expression and secretion by rat brain cells in vitro. J Neurosci Res 25(4):576–580
Facchini FS, Saylor KL (2002) Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate-intolerant patients. Ann N Y Acad Sci 967:342–351
Fairweather-Tait SJ, Wawer AA, Gillings R, Jennings A, Myint PK (2014) Iron status in the elderly. Mech Ageing Dev 136–137:22–28
Fargion S, Valenti L, Fracanzani AL (2014) Role of iron in hepatocellular carcinoma. Clinical Liver Diseas 5(3):108–110
Farhan S, Baber U, Mehran R (2016) Anemia and acute coronary syndrome: time for intervention studies. J Am Heart Assoc 5(11):pii:e004908
Fleming RE, Ponka P (2012) Iron overload in human disease. N Engl J Med 366(4):348–359
Fleming DJ, Jacques PF, Massaro JM, D’Agostino RB Sr, Wilson PW, Wood RJ (2001) Aspirin intake and the use of serum ferritin as a measure of iron status. Am J Clin Nutr 74(2):219–226
Fonseca-Nunes A, Jakszyn P, Agudo A (2014) Iron and cancer risk–a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomark Prev 23(1):12–31
Franco PG, Pasquini LA, Pérez MJ, Rosato-Siri MV, Silvestroff L, Pasquini JM (2015) Paving the way for adequate myelination: the contribution of galectin-3, transferrin and iron. FEBS Lett 589(22):3388–3395
Frazer DM, Anderson GJ (2005) Iron imports. I. Intestinal iron absorption and its regulation. Am J Physiol Gastrointest Liver Physiol 289:G631–G635
Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC, Hopkins PN, Cefalu WT, McClain DA (2012) Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122(10):3529–3540
Galaris D, Pantopoulos K (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci 45(1):1–23
Gammella E, Recalcati S, Rybinska I, Buratti P, Cairo G (2015) Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms. Oxid Med Cell Longev 2015:230182
Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434–1443
Gao Y, Li Z, Gabrielsen JS, Simcox JA, Lee SH, Jones D, Cooksey B, Stoddard G, Cefalu WT, McClain DA (2015) Adipocyte iron regulates leptin and food intake. J Clin Invest 125(9):3681–3691
Gellert S, Hahn A (2017) Iron status in relation to oral contraceptive use in women of reproductive age
Gilreath JA, Stenehjem DD, Rodgers GM (2012) Total dose iron dextran infusion in cancer patients: is it SaFe2+? J Natl Compr Canc Netw 10:669–676
Gotardo ÉM, dos Santos AN, Miyashiro RA, Gambero S, Rocha T, Ribeiro ML, Gambero A (2013) Mice that are fed a high-fat diet display increased hepcidin expression in adipose tissue. J Nutr Sci Vitaminol (Tokyo) 59(5):454–461
Götz ME, Double K, Gerlach M, Youdim MB, Riederer P (2004) The relevance of iron in the pathogenesis of Parkinson’s disease. Ann N Y Acad Sci 1012:193–208
Greene RJ, Hall AD, Hider RC (1990) The interaction of orally administered iron with levodopa and methyldopa therapy. J Pharm Pharmacol 42:502–504
Gu C, Karthikeyan KG (2005) Interaction of tetracycline with aluminum and iron hydrous oxides. Environ Sci Technol 39(8):2660–2667
Haddow A, Roe FJ, Mitchley BC (1964) Induction of Sarcomata in rabbits by intramuscular injection of iron–dextran (IMFERON). Br Med J 1(5398):1593–1594
Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74(6):848–861
Harris ZL (2003) Aceruloplasminemia. J Neurol Sci 207(1–2):108–109
Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512
Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117(3):285–297
Hirose W, Ikematsu K, Tsuda R (2003) Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med (Tokyo) 5(Suppl 1):S360–S366
Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI (2000) Alzheimer’s disease, beta-amyloid protein and zinc. J Nutr 130(5S Suppl):1488S–1492S
Hung N, Shen CC, Hu YW, Hu LY, Yeh CM, Teng CJ, Kuan AS, Chen SC, Chen TJ, Liu CJ (2015) Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study. PLoS ONE 10(3):e0119647
Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, Moestrup SK (2005) Identification of the receptor scavenging hemopexin-heme complexes. Blood 106:2572–2579
Iwabuchi T, Yoshimoto C, Shigetomi H, Kobayashi H (2015) Oxidative stress and antioxidant defense in endometriosis and its malignant transformation. Oxid Med Cell Longev 2015:848595
Jehn M, Clark JM, Guallar E (2004) Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diab Care 27(10):2422–2428
Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB (1990) Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases. J Neural Transm Park Dis Dement Sect 2(4):327–340
Jeong SY, David S (2006) Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin deficient mice. J Neurosci 26:9810–9819
Jiang L, Nagai H, Ohara H, Hara S, Tachibana M, Hirano S, Shinohara Y, Kohyama N, Akatsuka S, Toyokuni S (2008) Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci 99:2142–2151
Kang P, Liu T, Tian C, Zhou Y, Jia C (2012) Association of total iron binding capacity with coronary artery disease. Clin Chim Acta 413:1424–1429
Ke Y, Qian ZM (2007) Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 83:149–173
Killilea DW, Wong SL, Cahaya HS, Atamna H, Ames BN (2004) Iron accumulation during cellular senescence. Ann N Y Acad Sci 1019:365–367
Klang IM, Schilling B, Sorensen DJ, Sahu AK, Kapahi P, Andersen JK, Swoboda P, Killilea DW, Gibson BW, Lithgow GJ (2014) Lithgow GJ. Iron promotes protein insolubility and aging in C. elegans. Aging (Albany NY) 6(11):975–991
Knutson M, Wessling-Resnick M (2003) Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 38(1):61–88
Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39:687–699
Kumar MJ, Aandersen JK (2004) Perspectives on MAO-b in aging and neurological disease: where do we go from here? Mol Neurobiol 30:77–89
Kwik-Uribe CL, Golub MS, Keen CL (2000) Chronic marginal iron intakes during early development in mice alter brain iron concentrations and behavior despite postnatal iron supplementation. J Nutr 130(8):2040–2048
Latunde-Dada GO, McKie AT, Simpson RJ (2006) Animal models with enhanced erythropoiesis and iron absorption. Biochim Biophys Acta 1762(4):414–423
Lee SC, Park SW, Kim DK, Lee SH, Hong KP (2001) Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension 38(2):166–170
Leonard JP, Desager JP, Beckers C, Harvengt C (1979) In vitro binding of various biological substances by two hypocholesterolaemic resins. Cholestyramine and colestipol. Arzneimittelforschung 29(7):979–981
Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874
Lopez T, Schriner SE, Okoro M, Lu D, Chiang BT, Huey J, Jafari M (2014) Green tea polyphenols extend the lifespan of male drosophila melanogaster while impairing reproductive fitness. J Med Food 17(12):1314–1321
Lopez TE, Pham HM, Nguyen BV, Tahmasian Y, Ramsden S, Coskun V, Schriner SE, Jafari M (2016) Green tea polyphenols require the mitochondrial iron transporter, mitoferrin, for lifespan extension in Drosophila melanogaster. Arch Insect Biochem Physiol 93(4):210–221
Lopez-Contreras MJ, Zamora-Portero S, Lopez MA, Marin JF, Zamora S, Perez-Llamas F (2010) Dietary intake and iron status of institutionalized elderly people: relationship with different factors. J Nutr Health Aging 14(10):816–821
Lozano AM, Lang AE, Hutchison WD, Dostrovsky JO (1998) New developments in understanding the etiology of Parkinson’s disease and in its treatment. Curr Opin Neurobiol 8(6):783–790
Ludwig H, Müldür E, Endler G, Hübl W (2013) Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 24(7):1886–1892
Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, Fridrik M, Geissler D, Geissler K, Gisslinger H, Koller E, Kopetzky G, Lang A, Rumpold H, Steurer M, Kamali H, Link H (2015) Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr 127(23–24):907–919
Lyle WH (1976) Penicillamine and iron. Lancet 2(7982):420
Lynch SM, Frei BJ (1993) Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. Lipid Res 34(10):1745–1753
Ma YS, Wu SB, Lee WY, Cheng JS, Wei YH (2009) Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. Biochim Biophys Acta 1790(10):1021–1029
Martin TJ, Grill V (2000) Bisphosphonates—mechanisms of action. Exp Clin Pharmacol 23:130–132
McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, Simpson RJ (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291(5509):1755–1759
Mehrabani M, Djalali M, Sadeghi M, Hajibeigi B, Zeraati H, Fatehi F, Chamari M (2008) Association between blood donation frequency, antioxidant enzymes and lipid peroxidation. Acta Med Iran 46(5):361–366
Meroño O, Cladellas M, Ribas-Barquet N, Recasens L, Bazán V, Comín-Colet J (2016) Iron deficiency in patients with acute coronary syndrome: prevalence and predisposing factors. Rev Esp Cardiol (Engl Ed) 69(6):615–617
Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF (1997) Possible association of a reduction in cardiovascular events with blood donation. Heart 78:188–193
Milman N, Pedersen AN, Ovesen L, Schroll M (2008) Hemoglobin concentrations in 358 apparently healthy 80-year-old Danish men and women. Should the reference interval be adjusted for age? Aging Clin Exp Res 20(1):8–14
Moalem S, Percy ME, Andrews DF, Kruck TP, Wong S, Dalton AJ, Mehta P, Fedor B, Warren AC (2000) Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 93(1):58–66
Mobarra N, Shanaki M, Ehteram H, Nasiri H, Sahmani M, Saeidi M, Goudarzi M, Pourkarim H, Azad M (2016) A review on iron chelators in treatment of iron overload syndromes. Int J Hematol Oncol Stem Cell Res 10(4):239–247
Muñoz P, Humeres A, Elgueta C, Kirkwood A, Hidalgo C, Núñez MT (2011) Iron mediates N-methyl-d-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J Biol Chem 286(15):13382–13392
Murray MJ, Murray AB, Murray NJ (1991) Do iron and copper supplementation of the diet impair antioxidant activity and speed atherogenesis? Arterioscler Thromb 11:1479a
Nemeth E, Ganz T (2006) Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26:323–342
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004a) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090–2093
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T (2004b) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271–1276
Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110(7):1037–1044
Niederau C (2000) Iron overload and atherosclerosis. Hepatology 32:672–674
Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, Bianco A, Daniele A (2014) New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int 2014:658913
Nilsson-Ehle H, Jagenburg R, Landahl S, Svanborg A (2000) Blood haemoglobin declines in the elderly: implications for reference intervals from age 70 to 88. Eur J Haematol 65(5):297–305
Orr JS, Kennedy A, Anderson-Baucum EK, Webb CD, Fordahl SC, Erikson KM, Zhang Y, Etzerodt A, Moestrup SK, Hasty AH (2014) Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes 63(2):421–432
Pabis K, ScheiberMojdehkarb B, Valencakc T, Nowikovskya K (2017) Altered iron homeostasis in mouse models of aging. Eks Gerontol 94:118
Padwal MK, Murshid M, Nirmale P, Melinkeri RR (2015) Association of serum ferritin levels with metabolic syndrome and insulin resistance. J Clin Diagn Res 9(9):11–13
Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L (2012) Mechanisms of mammalian iron homeostasis. Biochemistry 51(29):5705–5724
Park S, Jung CW, Kim K, Kim SJ, Kim WS, Jang JH (2015) Iron deficient erythropoiesis might play key role in development of anemia in cancer patients. Oncotarget 6(40):42803–42812
Patel KV (2008) Epidemiology of anemia in older adults. Semin Hematol 45:210–217
Pennisi V (2017) Oral supplements and iron deficiency. Aust Prescr 40(2):50
Perry G, Sayre LM, Atwood CS, Castellani RJ, Cash AD, Rottkamp CA, Smith MA (2002) The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16(5):339–352
Pietrangelo A (2006) Hereditary hemochromatosis. Biochim Biophys Acta 1763:700–710
Pihan-Le Bars F, Bonnet F, Loréal O, Le Loupp AG, Ropert M, Letessier E, Prieur X, Bach K, Deugnier Y, Fromenty B, Cariou B (2016) Indicators of iron status are correlated with adiponectin expression in adipose tissue of patients with morbid obesity. Diabetes Metab 42(2):105–111
Pino JMV, da Luz MHM, Antunes HKM, Giampá SQC, Martins VR, Lee KS (2017) Iron-restricted diet affects brain ferritin levels, dopamine metabolism and cellular prion protein in a region-specific manner. Front Mol Neurosci 10:145
Pourmoghaddas A, Sanei H, Garakyaraghi M, Esteki-Ghashghaei F, Gharaati M (2014) The relation between body iron store and ferritin, and coronary artery disease. ARYA Atheroscler 10(1):32–36
Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA, Markesbery WR (2003) Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer’s disease and correlation with APOE. Am J Med Genet B Neuropsychiatr Genet 119B(1):48–53
Radlowski EC, Johnson RW (2013) Perinatal iron deficiency and neurocognitive development. Front Hum Neurosci 7:585
Rezazadeh H, Nayebi AR, Garjani A, Sheikhulislami A, Babaei H (2005) Evidence that iron overload plus croton oil induce skin tumours in mice. Hum Exp Toxicol 24(8):409–413
Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metalprotein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685–1691
Roger VL, Go AS (2013) Lloyd-antioxidants supplementation in elderly cardiovascular patients. Matilde Otero-Losa
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB (2012) American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics–2012 update: a report from the American heart association. Circulation 125(e1):e2–e220
Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L (1991) Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54(1):152–156
Rottkamp CA, Raina AK, Zhu X, Gaier E, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med 30(4):447–450
Rouault TA, Tong WH (2005) Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol 6(4):345–351
Runko AP, Griswold AJ, Min KT (2008) Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila. FEBS Lett 582(5):715–719
Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, Rostad B, Pachura K, Adams L, Elliott J, Taylor WR, Narula J, Kolodgie F, Virmani R, Hong CC, Finn AV (2012) Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol 32(2):299–307
Schiavi A, Maglioni S, Palikaras K, Shaik A, Strappazzon F, Brinkmann V, Torgovnick A, Castelein N, De Henau S, Braeckman BP, Cecconi F, Tavernarakis N, Ventura N (2015) Iron-starvation-induced mitophagy mediates lifespan extension upon mitochondrial stress in C. elegans. Curr Biol. 25(14):1810–1822
Schonberg DL, McTigue DM (2009) Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol 218(1):64–74
Schulz K, Kroner A, David S (2012) Iron efflux from astrocytes plays a role in remyelination. J Neurosci 32(14):4841–4847
Seo AY, Xu J, Servais S, Hofer T, Marzetti E, Wohlgemuth SE, Knutson MD, Chung HY, Leeuwenburgh C (2008) Mitochondrial iron accumulation with age and functional consequences. Aging Cell 7(5):706–716
Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB (2004) Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 46(2):254–263
Simcox JA, McClain DA (2013) Iron and diabetes risk. Cell Metab 17(3):329–341
Simpson RJ, McKie AT (2009) Regulation of intestinal iron absorption: the mucosa takes control? Cell Metab 10:84–87
Skikne BS (2008) Serum transferrin receptor. Am J Hematol 83(11):872–875
Skikne BS, Cook JD (1992) Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 120(5):746–751
Solomon A, Blum A, Peleg A, Lev EI, Leshem-Lev D, Hasin Y (2012) Endothelial progenitor cells are suppressed in anemic patients with acute coronary syndrome. Am J Med 125:604–611
Song D, Dunaief JL (2013) Retinal iron homeostasis in health and disease. Front Aging Neurosci 5:24
Srai SK, Chung B, Marks J, Pourvali K, Solanky N, Rapisarda C, Chaston TB, Hanif R, Unwin RJ, Debnam ES, Sharp PA (2010) Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure. Kidney Int 78(7):660–667
Sripetchwandee J, Pipatpiboon N, Chattipakorn N, Chattipakorn S (2014) Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity. PLoS ONE 9(1):e85115
Sullivan JL (1989) The iron paradigm of ischemic heart disease. Am Heart J 117:1177–1188
Sultan S, Murarka S, Jahangir A, Mookadam F, Tajik AJ, Jahangir A (2017) Chelation therapy in cardiovascular disease: an update. Expert Rev Clin Pharmacol 10(8):843–854
Tajima S, Ikeda Y, Sawada K, Yamano N, Horinouchi Y, Kihira Y, Ishizawa K, Izawa-Ishizawa Y, Kawazoe K, Tomita S, Minakuchi K, Tsuchiya K, Tamaki T (2012) Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 302(1):E77–E86
Takami T, Sakaida I (2011) Iron regulation by hepatocytes and free radicals. J Clin Biochem Nutr 48(2):103–106
Teucher B, Olivares M, Cori H (2004) Enhancers of iron absorption: ascorbic acid and other organic acids. Int J Vitam Nutr Res 74(6):403–419
Thompson K et al (2003) Mouse brains deficient in h-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J. Neurosci. Res. 71:46–63
Toyokuni S (2008) Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 60(7):441–447
Toyokuni S (2011) Iron as a target of chemoprevention for longevity in humans. Free Radic Res 45(8):906–917
Trumbo P, Yates AA, Schlicker S, Poos M (2001) Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 101(3):294–301
Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT (1997) Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 314:793–794
Tussing-Humphreys L, Pusatcioglu C, Pustacioglu C, Nemeth E, Braun-schweig C (2012) Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. J Acad NutrDiet 112:391–400
Uversky VN, Li J, Fink AL (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson’s disease and heavy metal exposure. J Biol Chem. 276(47):44284–44296
Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S (2007) Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 102(6):1251–1258
Valentini S, Cabreiro F, Ackerman D, Alam MM, Kunze MB, Kay CW, Gems D (2012) Manipulation of in vivo iron levels can alter resistance to oxidative stress without affecting ageing in the nematode C. elegans. Mech Ageing Dev 133(5):282–290
Vaquero MP, Sánchez-Muniz FJ, Carbajal A, García-Linares MC, García-Fernández MC, García-Arias MT (2004) Mineral and vitamin status in elderly persons from Northwest Spain consuming an Atlantic variant of the Mediterranean diet. Ann Nutr Metab 48(3):125–133
Vinchi F, Muckenthaler MU, Da Silva MC, Balla G, Balla J, Jeney V (2014) Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol 5:94
von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD (2015) Iron deficiency and cardiovascular disease. Nat Rev Cardiol 12(11):659–669
Waldvogel-Abramowski S, Waeber G, Gassner C, Buser A, Frey BM, Favrat B, Tissota JD (2014) Physiology of Iron metabolism. Transfus Med Hemother 41(3):213–221
Wang L, Johnson EE, Shi HN, WalkerWA Wessling-Resnick M, Cherayil BJ (2008) Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J Immunol 181:2723–2731
Weigel KJ, Lynch SG, LeVine SM (2014) Iron chelation and multiple sclerosis. ASN Neuro 6(1):e00136
Weiss G, Werner-Felmayer G, Werner ER, Grünewald K, Wachter H, Hentze MW (1994) Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 180(3):969–976
Wessling-Resnick M (2006) Iron imports. III. Transfer of iron from the mucosa into circulation. Am J Physiol Gastrointest Liver Physiol 290(1):G1–G6
West AR, Oates PS (2008) Mechanisms of heme iron absorption: current questions and controversies. World J Gastroenterol 14(26):4101–4110
White DL, Collinson A (2013) Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts. Adv Nutr 4(4):403–411
Williams R, Buchheit CL, Berman NE, LeVine SM (2012) Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 120(1):7–25
Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, van der Kallen CJ, Schalkwijk CG, Bravenboer B, Stehouwer CD (2013) Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Diab Care 36(2):309–315
Wyllie S, Liehr JG (1998) Enhancement of estrogen-induced renal tumorigenesis in hamsters by dietary iron. Carcinogenesis 19(7):1285–1290
Yang H, Youm YH, Vandanmagsar B, Rood J, Kumar KG, Butler AA, Dixit VD (2009) Obesity accelerates thymic aging. Blood 114:3803–3812
Yien YY, Paw BH (2016) A role for iron deficiency in dopaminergic neurodegeneration. Proc Natl Acad Sci U S A 113(13):3417–3418
Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5(11):863–873
Zijp IM, Korver O, Tijburg LB (2000) Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 40(5):371–398
Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol 155:96–119
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Grubić Kezele, T. (2018). Iron. In: Malavolta, M., Mocchegiani, E. (eds) Trace Elements and Minerals in Health and Longevity. Healthy Ageing and Longevity, vol 8. Springer, Cham. https://doi.org/10.1007/978-3-030-03742-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-03742-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03741-3
Online ISBN: 978-3-030-03742-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)